The Institute of Medical Sciences, Banaras Hindu University, will start study of using Ashwagandha (Withania somnifera) as a test drug for prophylactic use among front line health workersaworkers Yashtimadhu (Glycyrrhiza glabra) for adjunct therapy with the standard treatment of conventional medicine like allopathy on Covid-19 patients with mild and moderate symptoms.
Head of the department of Rasa Shastra, of ayurveda faculty IMS-BHU and centre coordinator for the project Prof. Anand Chaudhary said, “As a part of the project of ministry of AYUSH, Indian Council of Medical Research and Council of Scientific and Industrial Research launched by Union health and family welfare minister Dr Harshvardhan and Dr Rajesh Kotecha, secretary of ministry of AYUSH on May 9, the university was given assigned the task of conducting studies on Ashwagandha and Yashtimadhu.”
Comments
Post a Comment
Thank you for your comment. Stay Home! Stay Safe